1. Home
  2. Live Updates
  3. Frontline pembrolizumab plus chemotherapy

Live Breaking News & Updates on Frontline Pembrolizumab Plus Chemotherapy |Page 1

Stay updated with breaking news from Frontline pembrolizumab plus chemotherapy . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Shah on 5-Year Outcomes With Pembrolizumab/Chemo in Esophageal Cancer

Manish A. Shah, MD, discusses 5-year outcomes from the KEYNOTE-590 trial of frontline pembrolizumab plus chemotherapy in patients with esophageal cancer. ....

Manisha Shah , Solid Tumor Service , Gastrointestinal Oncology Program , Weill Cornell Medicine , Advanced Digestive Disease , Newyork Presbyterian , Keynote 590 Trial , Frontline Pembrolizumab Plus Chemotherapy , Patients With Esophageal Cancer ,